Phase II study of 'dose-dense' high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
収録刊行物
-
- J. Clin. Oncol.
-
J. Clin. Oncol. 16 1852-1860, 1998